Copellor 80 mg/ml Solution for injection
PDF Leaflet Revision Date: 22 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Moderate to severe plaque psoriasis, psoriatic arthritis, axial spondyloarthritis.
Dosage (summary)
160 mg subcutaneously at Week 0, then 80 mg every 4 weeks for maintenance.
Onset of Action / Duration
Onset: 2 weeks, Duration: 4 weeks
Special Populations
- Elderly (u2265 65 years)
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; avoid breastfeeding.
Key Drug Interactions
- Live vaccines
- Immunomodulatory agents
Contraindications
- Hypersensitivity to ixekizumab
- Active infections
- Live attenuated vaccines
Common side effects
- Injection site reactions
- Upper respiratory tract infections
- Nausea
Counselling Points
- Monitor for infections
- Avoid live vaccines
- Report any severe allergic reactions
Serious warnings
- Increased risk of infections
- Serious hypersensitivity reactions
- Inflammatory bowel disease exacerbation
Important Disclaimer
The Copellor 80 mg/ml Solution for injection professional information leaflet below is the property of Eli Lilly (SA) and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
